Warren opposition to patents and intellectual property in USMCA puts live-saving treatments at risk

Aug. 1, 2019, Fairfax, Va.—Americans for Limited Government President Rick Manning today issued the following statement blasting Sen. Elizabeth Warren (D-Mass.) for opposing patents and intellectual property for life-saving pharmaceuticals in the Democratic debate:

“Elizabeth Warren was dead wrong when she chose to attack the intellectual property protections contained within the US-Mexico-Canada trade agreement.  Her focus on the intellectual property rights of those who develop life-saving drugs and biologics should concern every person in America who is hoping to see an end to Alzheimer’s disease, various cancers and other lesser known diseases like dengue fever in our lifetimes.  Intellectual property protection is the simple concept that drives innovation as it guarantees that those who take the risks get to recoup a profit from taking those risks.  Unfortunately, Elizabeth Warren and those of her ilk, reject this fundamental concept, and as a result would tear away the incentive to invest in new drug development.

“The future of medicine is rapidly changing with innovations in nano-technology, robotics and biologics poised to change many of today’s assumptions about longevity and treatment.  It would be foolish to follow the rearview mirror focused approach of those like Warren who would stifle this bright future for human wellness by denying the financial incentives to make it a reality.”

Interview Availability: Please contact Americans for Limited Government at 703-383-0880 ext. 1 or at media@limitgov.org

###

Print Friendly, PDF & Email